Oscar Health, Inc. (NYSE:OSCR – Get Free Report) was up 4.5% during mid-day trading on Tuesday . The stock traded as high as $15.52 and last traded at $15.47. Approximately 863,308 shares traded hands during trading, a decline of 73% from the average daily volume of 3,184,488 shares. The stock had previously closed at $14.80.
Analyst Upgrades and Downgrades
OSCR has been the subject of a number of research analyst reports. Wells Fargo & Company increased their target price on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. The Goldman Sachs Group increased their target price on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a report on Friday, February 9th. Raymond James initiated coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 target price for the company. Finally, TheStreet raised shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $13.50.
Oscar Health Stock Performance
The stock’s 50-day moving average is $15.25 and its 200-day moving average is $10.68. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of -13.07 and a beta of 1.79. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. Oscar Health’s revenue for the quarter was up 43.9% on a year-over-year basis. During the same quarter last year, the business earned ($1.05) EPS. Analysts anticipate that Oscar Health, Inc. will post -0.23 EPS for the current fiscal year.
Hedge Funds Weigh In On Oscar Health
Several hedge funds and other institutional investors have recently made changes to their positions in OSCR. Envestnet Asset Management Inc. purchased a new stake in Oscar Health during the 1st quarter worth $164,000. Advisor Group Holdings Inc. increased its stake in Oscar Health by 157.5% during the 1st quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock worth $101,000 after buying an additional 6,182 shares during the period. Swiss National Bank increased its stake in Oscar Health by 8.6% during the 1st quarter. Swiss National Bank now owns 103,100 shares of the company’s stock worth $1,028,000 after buying an additional 8,200 shares during the period. Ergoteles LLC purchased a new stake in Oscar Health during the 1st quarter worth $633,000. Finally, Charles Schwab Investment Management Inc. increased its stake in Oscar Health by 2.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 193,504 shares of the company’s stock worth $1,930,000 after buying an additional 4,801 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.